See more : Thermo Fisher Scientific Inc. (0R0H.L) Income Statement Analysis – Financial Results
Complete financial analysis of Telescope Innovations Corp. (TELIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Telescope Innovations Corp., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Americas Technology Acquisition Corp. (ATA-UN) Income Statement Analysis – Financial Results
- Witan Investment Trust plc (WTAN.L) Income Statement Analysis – Financial Results
- Hill International, Inc. (HIL) Income Statement Analysis – Financial Results
- Expand Energy Corporation (EXE) Income Statement Analysis – Financial Results
- Riverview Financial Corporation (RIVE) Income Statement Analysis – Financial Results
Telescope Innovations Corp. (TELIF)
About Telescope Innovations Corp.
Telescope Innovations Corp., a chemical technology company, engages in developing synthetic processes to access pharmaceuticals for the treatment of mental health. The company is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 2.82M | 595.40K | 0.00 | 0.00 |
| Cost of Revenue | 3.50K | 930.15K | 15.65K | 0.00 |
| Gross Profit | 2.82M | -334.75K | -15.65K | 0.00 |
| Gross Profit Ratio | 99.88% | -56.22% | 0.00% | 0.00% |
| Research & Development | 0.00 | 59.56K | 129.83K | 221.25K |
| General & Administrative | 2.25M | 5.60M | 3.72M | 140.06K |
| Selling & Marketing | 82.85K | 13.32K | 4.90K | 20.16K |
| SG&A | 2.33M | 5.62M | 3.72M | 31.73K |
| Other Expenses | 0.00 | -930.15K | -15.65K | 0.00 |
| Operating Expenses | 3.54M | 6.35M | 4.02M | 252.98K |
| Cost & Expenses | 3.55M | 6.35M | 4.02M | 252.98K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 2.44K |
| Depreciation & Amortization | 303.60K | 276.34K | 236.56K | 206.30K |
| EBITDA | -421.78K | -5.49M | -4.02M | -252.98K |
| EBITDA Ratio | -14.94% | -922.15% | 0.00% | 0.00% |
| Operating Income | -725.38K | -5.77M | -4.02M | -252.98K |
| Operating Income Ratio | -25.69% | -968.56% | 0.00% | 0.00% |
| Total Other Income/Expenses | 3.64K | 9.87K | -1.71K | 2.00 |
| Income Before Tax | -718.09K | -5.75M | -4.03M | -252.98K |
| Income Before Tax Ratio | -25.43% | -965.24% | 0.00% | 0.00% |
| Income Tax Expense | -3.64K | -9.87K | -885.06K | -233.52K |
| Net Income | -718.09K | -5.75M | -4.03M | -252.98K |
| Net Income Ratio | -25.43% | -965.24% | 0.00% | 0.00% |
| EPS | -0.01 | -0.12 | -0.08 | -0.01 |
| EPS Diluted | -0.01 | -0.12 | -0.08 | -0.01 |
| Weighted Avg Shares Out | 52.72M | 48.42M | 47.79M | 47.79M |
| Weighted Avg Shares Out (Dil) | 52.72M | 48.42M | 47.79M | 47.79M |
Telescope Innovations Becomes Certified Systems Integrator of Universal Robots
Certification enables faster development and deployment of Telescope's Self-Driving Labs Vancouver, British Columbia--(Newsfile Corp. - October 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a developer of enabling technologies and services for the...
Telescope Innovations and Altillion Inc. Showcase Proprietary, Simplified Production of Battery-Quality Lithium Carbonate from Brines
Telescope's proprietary ReCRFT process produces >99.5% pure lithium carbonate from Altillion's brine concentrates Vancouver, British Columbia--(Newsfile Corp. - September 17, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a leading developer of advanced technologies...
Telescope Innovations and Standard Lithium Demonstrate Low-Temperature, High-Purity Production of Lithium Sulfide for Solid-State Batteries
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope Innovations" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces the successful outcome...
Telescope Innovations and Pfizer Sign Master Collaborative Research Agreement
Funding from and collaboration with Pfizer could facilitate Telescope's growth and R&D advancement Vancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies and services...
Telescope Innovations Receives CICE Funding to Pilot Lithium Refinement Technology
Vancouver, British Columbia--(Newsfile Corp. - July 22, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been awarded $400,273 in early-stage...
Telescope Innovations Presents Results of Third Fiscal Quarter 2024
Year-to-date revenues surpass entire fiscal year 2023 Vancouver, British Columbia--(Newsfile Corp. - July 11, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries,...
Telescope Innovations Joins MaRS: North America's Largest Urban Innovation Hub
Vancouver, British Columbia--(Newsfile Corp. - June 24, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been accepted as a member...
Telescope Innovations to Participate in Lithium Supply and Battery Raw Materials Conference 2024
Vancouver, British Columbia--(Newsfile Corp. - June 11, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce its participation...
Telescope Innovations to Showcase DirectInject-LC(TM) Product and Process IP at METTLER TOLEDO Events
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce its participation...
Telescope Innovations Presents Results of Second Fiscal Quarter 2024
Vancouver, British Columbia--(Newsfile Corp. - April 18, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results and operational highlights...
Source: https://incomestatements.info
Category: Stock Reports